HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Laryngeal Neoplasms D007822 7 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Respiratory Sounds D012135 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Hirschsprung Disease D006627 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Mercury Poisoning, Nervous System D020262 2 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Eosinophilic Esophagitis D057765 3 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Mucinoses D017520 2 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Dysentery, Amebic D004404 3 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Thyroid Nodule D016606 4 associated lipids
Glucagonoma D005935 2 associated lipids
Vascular Neoplasms D019043 2 associated lipids
Fetomaternal Transfusion D005331 1 associated lipids
Schistosomiasis haematobia D012553 1 associated lipids
Paraganglioma, Extra-Adrenal D010236 1 associated lipids
Mesonephroma D008649 1 associated lipids
Adenoma, Oxyphilic D018249 1 associated lipids
Adenoma, Pleomorphic D008949 1 associated lipids
Odontogenic Cyst, Calcifying D018333 1 associated lipids
Lip Neoplasms D008048 3 associated lipids
Prostatic Intraepithelial Neoplasia D019048 1 associated lipids
Granular Cell Tumor D016586 1 associated lipids
Tooth Attrition D019217 1 associated lipids
Acanthamoeba Keratitis D015823 1 associated lipids
Cystadenocarcinoma, Papillary D018283 1 associated lipids
Nevus, Epithelioid and Spindle Cell D018332 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Rhabdomyoma D012207 1 associated lipids
Angiomyolipoma D018207 1 associated lipids
Sertoli Cell Tumor D012707 1 associated lipids
Neoplasms, Fibroepithelial D018225 1 associated lipids
Dientamoebiasis D004030 1 associated lipids
HIV Enteropathy D019053 1 associated lipids
Linear IgA Bullous Dermatosis D062027 1 associated lipids
Equine Infectious Anemia D004859 1 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Berney DM et al. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. 2009 Br. J. Cancer pmid:19293807
Rogers HA et al. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). 2009 Br. J. Cancer pmid:19293793
Kawanishi H et al. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. 2007 Br. J. Cancer pmid:17579624
Modok S et al. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. 2007 Br. J. Cancer pmid:17579620
Nakagawa S et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. 2004 Br. J. Cancer pmid:14710229
Yoshikawa R et al. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. 2008 Br. J. Cancer pmid:18475300
Hamma-Kourbali Y et al. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice. 2003 Br. J. Cancer pmid:12838326
Yao H et al. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. 2004 Br. J. Cancer pmid:15494722
Pardo FS et al. Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. 2004 Br. J. Cancer pmid:15494720
Tang Z et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. 2008 Br. J. Cancer pmid:19238632
Abd El-Rehim DM et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. 2004 Br. J. Cancer pmid:15480434
Hussain SA et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:12592374
Spizzo G et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. 2003 Br. J. Cancer pmid:12592372
Pelosi G et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. 2003 Br. J. Cancer pmid:12592367
Nishikawa M et al. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. 2005 Br. J. Cancer pmid:15956973
Pattje WJ et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. 2010 Br. J. Cancer pmid:20502457
Onda M et al. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. 2005 Br. J. Cancer pmid:15956966
Kim MS et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. 2008 Br. J. Cancer pmid:18392055
O'Callaghan G et al. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. 2008 Br. J. Cancer pmid:18648368
Moniaux N et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. 2008 Br. J. Cancer pmid:18392050
Ni X et al. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. 2004 Br. J. Cancer pmid:15305183
Elkahwaji JE et al. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. 2009 Br. J. Cancer pmid:19844236
Yamato I et al. Clinical importance of B7-H3 expression in human pancreatic cancer. 2009 Br. J. Cancer pmid:19844235
Andersen CL et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. 2009 Br. J. Cancer pmid:19156145
Sersa G et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. 2002 Br. J. Cancer pmid:12434299
Fan LZ and Cherian MG Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. 2002 Br. J. Cancer pmid:12434295
de Micco C et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. 2008 Br. J. Cancer pmid:18212751
Nehls O et al. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. 2007 Br. J. Cancer pmid:17426704
Thews O et al. Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. 2004 Br. J. Cancer pmid:15305198
Gaballah K et al. The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. 2009 Br. J. Cancer pmid:19623179
Elie C et al. Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group). 2004 Br. J. Cancer pmid:15226774
Lawson JS et al. Koilocytes indicate a role for human papilloma virus in breast cancer. 2009 Br. J. Cancer pmid:19773762
Ogawa E et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. 2004 Br. J. Cancer pmid:15226767
Collet JF et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. 2005 Br. J. Cancer pmid:16251880
Chen YL et al. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. 2002 Br. J. Cancer pmid:12177809
Baeten CI et al. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. 2002 Br. J. Cancer pmid:12177806
Somlo G et al. Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. 2002 Br. J. Cancer pmid:12177795
Hettiaratchi A et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. 2007 Br. J. Cancer pmid:17311017
Janssen CS et al. The T1799A point mutation is present in posterior uveal melanoma. 2008 Br. J. Cancer pmid:18985043
van Beers EH et al. A multiplex PCR predictor for aCGH success of FFPE samples. 2006 Br. J. Cancer pmid:16333309
Ding SL et al. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. 2004 Br. J. Cancer pmid:15138484
Patmore HS et al. Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? 2004 Br. J. Cancer pmid:15138481
Sivridis E et al. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. 2002 Br. J. Cancer pmid:11986782
Hildenbrand R and Arens N Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. 2004 Br. J. Cancer pmid:15226768
Bignotti E et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 2011 Br. J. Cancer pmid:21468050
Garcia S et al. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. 2007 Br. J. Cancer pmid:17242702
Hagemann T et al. Molecular profiling of cervical cancer progression. 2007 Br. J. Cancer pmid:17242701
Kommoss S et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. 2007 Br. J. Cancer pmid:17242700
Killeen SD et al. Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastases. 2007 Br. J. Cancer pmid:17242699
Ueno Y et al. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. 2005 Br. J. Cancer pmid:15841081
Kato T et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. 2005 Br. J. Cancer pmid:16251871
Preuss SF et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. 2008 Br. J. Cancer pmid:18212752
Kölby L et al. Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour. 2005 Br. J. Cancer pmid:16251870
Dai DL et al. Reduced Apaf-1 expression in human cutaneous melanomas. 2004 Br. J. Cancer pmid:15305193
Wang JH et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. 2008 Br. J. Cancer pmid:18212749
Grützmann R et al. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. 2004 Br. J. Cancer pmid:14997207
Vicent S et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. 2004 Br. J. Cancer pmid:14997206
Savinainen KJ et al. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer. 2004 Br. J. Cancer pmid:14997205
Adam PJ et al. CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding. 2006 Br. J. Cancer pmid:16892042
Awwad HK et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. 2002 Br. J. Cancer pmid:11870530
Rofstad EK and Halsør EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. 2002 Br. J. Cancer pmid:11870523
Cheng Q et al. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 2002 Br. J. Cancer pmid:11870519
Brooks LA et al. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. 2002 Br. J. Cancer pmid:11870517
Koumakpayi IH et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. 2010 Br. J. Cancer pmid:20216540
Watermann DO et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. 2005 Br. J. Cancer pmid:16136050
Barros-Silva JD et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. 2009 Br. J. Cancer pmid:19156142
Theodore Ch et al. Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy. 2004 Br. J. Cancer pmid:14710206
Mizukami Y et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18841157
Van der Auwera I et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. 2008 Br. J. Cancer pmid:18841156
Deans DA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. 2006 Br. J. Cancer pmid:17088911
Stecker K et al. Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. 2011 Br. J. Cancer pmid:21468049
Lopez-Crapez E et al. p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis. 2005 Br. J. Cancer pmid:15956964
Dangles V et al. Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. 2002 Br. J. Cancer pmid:11953886
Rand V et al. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. 2008 Br. J. Cancer pmid:18781180
Debergh I et al. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. 2010 Br. J. Cancer pmid:20125158
Liao YH et al. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma. 2011 Br. J. Cancer pmid:21343931
Kikuchi M et al. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. 2009 Br. J. Cancer pmid:19491899
Jenkinson SR et al. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. 2004 Br. J. Cancer pmid:14710237
Ugurel S et al. Lack of clinical efficacy of imatinib in metastatic melanoma. 2005 Br. J. Cancer pmid:15846297
Brown NS et al. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. 2005 Br. J. Cancer pmid:15841086
Langbein S et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 2006 Br. J. Cancer pmid:16465194
Wülfing P et al. Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. 2005 Br. J. Cancer pmid:15841074
Hudelist G et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. 2003 Br. J. Cancer pmid:12966413
Vernimmen D et al. Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers. 2003 Br. J. Cancer pmid:12942124
Surowiak P et al. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. 2006 Br. J. Cancer pmid:16892043
Seynhaeve AL et al. Isolated limb perfusion with actinomycin D and TNF-alpha results in improved tumour response in soft-tissue sarcoma-bearing rats but is accompanied by severe local toxicity. 2002 Br. J. Cancer pmid:11953868
Baker MJ et al. FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. 2008 Br. J. Cancer pmid:18985044
Hartana CA et al. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours. 2016 Br. J. Cancer pmid:27599044
Nonomura N et al. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. 2007 Br. J. Cancer pmid:17848955
Zvereff V et al. Colocalisation of CD9 and mortalin in CD9-induced mitotic catastrophe in human prostate cancer cells. 2007 Br. J. Cancer pmid:17848953
Seenath MM et al. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008 Br. J. Cancer pmid:18648372
Lawrie LC et al. Liver fatty acid binding protein expression in colorectal neoplasia. 2004 Br. J. Cancer pmid:15138477
Landers KA et al. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. 2008 Br. J. Cancer pmid:18648369
Fondevila C et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. 2004 Br. J. Cancer pmid:14710231
Hashida H et al. Clinical significance of transmembrane 4 superfamily in colon cancer. 2003 Br. J. Cancer pmid:12838318
Yamamoto T et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. 2003 Br. J. Cancer pmid:12838317
Shyu RY et al. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. 2003 Br. J. Cancer pmid:12838316
Southern SA et al. Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. 2004 Br. J. Cancer pmid:15138476
Górka B et al. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. 2007 Br. J. Cancer pmid:17667921
Minas V et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. 2007 Br. J. Cancer pmid:17667919